In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

epilepsy

vestibular disorder

no signed informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • In vitro exposure to workplace by VR plus care as usual

    Other intervention

    During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace using VR glasses. Based on the experience of the participants during the vitual visit to their workplace, the psychologist can adjust the therapy. In addition care as usual is provided (see description active comparator).

  • Care as usual: Guidance from occupational physician and psychologist focused on returning to work

    Other intervention

    Guidance by the occupational physician and a psychologist from a psychologist practice specialized in counseling cabin crew and guiding them with returning to work.

Treatment groups

118 Participants
are divided into 2 treatment groups
Group A: Care as usual plus VRExperimental treatment 1 intervention
Group B: Care as usualActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time to RTW

Time between start of sickness absence until participant is considered 'fit to fly' by the occupational physician, measured by register data from the occupational health service.

Time frame
6 months and 12 months after baseline

Secondary outcomes

1

Stress-related complaints

Stress-related complaints (e.g., type of disease, severity of symptoms) by means of Perceived Stress Scale (PSS-10). The PSS-10 consists of 10 items rated on a 5-point Likert scale, ranging from 0 (never) to 4 (very often). A high score means more stress-related complaints

Time frame
Baseline and 4-months follow-up
2

Self-efficacy regarding return to work

Self-efficacy regarding return to work measured by Return-to-Work Self-Efficacy scale (RTW-SE). The RTW-SE contains of 11 items. The items are rated on a five point scale The response categories vary from 1 (totally disagree) to 6 (totally agree). A high score means more return to work self-efficacy

Time frame
Baseline and 4-months follow-up
3

Attitude regarding return to work

Scale on attitude regarding return to work. Attitude regarding return to work is measured with a 8-item scale measuring the attitude towards working again. The items are rated on a 4-point scale ranging from 1 (disagree very strongly) to 4 (agree very strongly). A higher score means a more positive attitude towards return to work.

Time frame
Baseline and 4-months follow-up
4

Job anxiety

Anxiety related to the job measured by the Job Anxiety Scale. The items are rated on a 5-point Likert scale, ranging from of 0 (no agreement) to 4 (full agreement). A higher score means more job anxiety.

Time frame
Baseline and 4-months follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead sponsor

KLM Royal Dutch Airlines

Collaborator

KLM Health Services

Collaborator

Villa Uitzicht

Collaborator